A protein additive for improving the quality of yak frozen semen, its preparation method and application

By adding recombinant yak HSPA8 protein to the cryoprotectant solution for yak semen, the problems of ice crystal damage, chemical toxicity, and oxidative stress during the freezing process were solved, which improved the sperm motility, plasma membrane integrity, and acrosome integrity of frozen yak semen, reduced the apoptosis rate, and improved the quality of frozen semen.

CN123106870APending Publication Date: 2026-11-17TIBET AGRI & ANIMAL HUSBANDRY COLLEGE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611418670.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-14
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing sperm cryopreservation technologies face three major challenges: ice crystal damage, chemical toxicity, and oxidative stress, which lead to sperm cell death and decreased quality, affecting conception rates.

Method used

Recombinant yak HSPA8 protein was used as a protein additive and added to yak semen cryoprotectant. It was efficiently prepared and purified using an E. coli expression system to a concentration of 0.8 µg/mL and used as a cryoprotectant for yak semen.

Benefits of technology

It significantly improved sperm motility, plasma membrane integrity, and acrosome integrity in frozen yak semen, reduced apoptosis rate, and improved the quality of frozen semen.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106870A_ABST
    Figure CN123106870A_ABST
Patent Text Reader

Abstract

This invention discloses a protein additive for improving the quality of yak frozen semen, its preparation method, and its application, relating to the field of pharmaceutical biotechnology. Addressing the problem of decreased sperm quality due to ice crystal damage and oxidative stress during yak semen cryopreservation, this invention provides a recombinant yak HSPA8 protein as a cryoprotective additive. This protein is obtained by acquiring the full gene sequence of yak HSPA8, synthesizing an expression plasmid, transforming it into competent E. coli cells, inducing expression, and purifying it. Adding this protein additive to yak semen cryoprotective solution at a concentration of 0.5–1.0 µg / mL significantly improves sperm viability, plasma membrane integrity, and acrosome integrity after thawing, and reduces sperm apoptosis rate. This invention is the first to utilize HSPA8 protein derived from the yak's own genes for semen cryopreservation, providing an efficient and safe solution for the preservation of yak germplasm resources.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pharmaceutical biotechnology, and more specifically to a protein additive for improving the quality of yak frozen semen, its preparation method, and its application. Background Technology

[0002] Currently, semen preservation technology, as a key technology for preserving superior male livestock germplasm resources and promoting the development of modern animal husbandry, has been widely applied in the breeding of animals such as pigs, cattle, and sheep. Semen freezing not only helps maintain the genetic stability of breeds but also accelerates the rate of genetic improvement and increases the conception rate of female animals through standardized procedures. However, animal semen freezing is affected by factors such as the cryopreservation solution, cooling procedure, and preservation method. After thawing, it often results in problems such as the death of a large number of sperm cells and a decline in overall quality due to freezing damage mechanisms.

[0003] During freezing, the phase transition of water inside and outside cells is the main cause of sperm death. While existing cryoprotectants can lower the freezing point, improperly controlled cooling rates can easily lead to the formation of intracellular ice crystals or a hypertonic extracellular environment. Intracellular ice crystals can directly puncture sperm cell membranes and organelles such as mitochondrial membranes, causing irreversible mechanical damage; while the growth of extracellular ice crystals can lead to excessively high local solute concentrations, producing a severe "solution effect," causing sperm dehydration, shrinkage, and even death. To inhibit ice crystal growth, existing cryoprotectants typically require the addition of high concentrations of osmotic protectants (such as glycerol and ethylene glycol). However, these chemical reagents are significantly toxic to sperm at high concentrations, disrupting the lipid bilayer structure of the sperm plasma membrane, interfering with sperm energy metabolism, and causing a rapid decline in sperm motility after thawing. How to reduce the toxic side effects of protectants while ensuring effective cryoprotection is a pressing problem that needs to be solved.

[0004] In addition, the freezing process induces sperm to produce excessive reactive oxygen species (ROS). Sperm cell membranes are rich in polyunsaturated fatty acids, making them highly susceptible to ROS attack and lipid peroxidation, leading to reduced membrane fluidity and altered permeability. Furthermore, mitochondria, as the primary site of ROS production, are directly affected by damage, resulting in insufficient ATP synthesis and consequently impacting sperm motility and fertilization capacity. Existing conventional cryoprotective solutions often lack effective antioxidant mechanisms and cannot effectively eliminate the oxidative stress generated during freezing. Cryopreservation damage also leads to decreased acrosomal enzyme activity, impaired acrosomal structural integrity, and increased DNA fragmentation. While these microstructural damages may not be readily apparent in routine semen analysis, they significantly affect sperm capacitation in the female reproductive tract and subsequent embryonic development potential.

[0005] In summary, existing semen cryopreservation technologies still face the triple challenges of ice crystal damage, chemical toxicity, and oxidative stress. Therefore, developing a high-efficiency semen cryopreservation technology or novel additives that can effectively inhibit ice crystal growth, reduce chemical toxicity, and maintain sperm physiological function is of significant application value for improving the quality and conception rate of frozen animal semen. Summary of the Invention

[0006] In view of this, the present invention provides a protein additive for improving the quality of yak frozen semen, its preparation method and application.

[0007] To achieve the above objectives, the present invention adopts the following technical solution:

[0008] A protein additive for improving the quality of yak frozen semen, wherein the protein additive is recombinant yak HSPA8 protein, the amino acid sequence of which is shown in SEQ ID NO: 2.

[0009] Furthermore, the recombinant yak HSPA8 protein was obtained by expression in an Escherichia coli expression system.

[0010] Furthermore, the concentration of the protein additive in the yak semen cryoprotectant is 0.5–1.0 µg / mL.

[0011] Furthermore, the concentration of the protein additive in the yak semen cryoprotectant is 0.8 µg / mL.

[0012] Application of a protein additive for improving the quality of yak frozen semen in the preparation of a cryoprotectant for yak semen.

[0013] A yak semen cryoprotectant comprising the protein additive and sperm cryoprotectant as described in any one of claims 1-4.

[0014] Furthermore, the final concentration of the protein additive in the yak semen cryoprotectant is 0.8 µg / mL.

[0015] A method for preparing a protein additive to improve the quality of yak frozen semen includes the following steps: (1) Obtain the full gene sequence of HSPA8 from yak and synthesize HSPA8 expression plasmid; (2) The expression plasmid was transformed into competent E. coli cells, and positive clones were screened; (3) Positive clones were induced to express, the bacterial cells were collected and lysed, and the recombinant yak HSPA8 protein was obtained by purification.

[0016] Furthermore, the conditions for inducing expression in step (3) are: IPTG final concentration 1 mmol / L, 37 ℃, 200 r / min induction culture for 4 hours; the purification is performed by Ni resin affinity chromatography.

[0017] A method for improving the quality of frozen yak semen involves adding the aforementioned protein additive to the semen or sperm cryopreservation solution before cryopreservation, such that the final concentration of the protein additive is 0.8 µg / mL.

[0018] As can be seen from the above technical solution, compared with the prior art, the beneficial effects of the present invention are as follows: The HSPA8 protein additive in the sperm cryopreservation solution used in this invention is derived from the yak itself. At the genetic level, it can reduce damage to yak sperm.

[0019] HSPA8 protein can be transferred into competent cells (such as E. coli) via plasmid, and its expression can be induced in large quantities in a short time (37 ℃, 4 h). It can then be purified and detoxified, which is convenient and quick.

[0020] When HSPA8 protein is added during the freezing of yak semen, it can effectively increase sperm motility by 3% to 10%, improve sperm plasma membrane integrity by 10% to 20%, and improve sperm acrosome integrity by 2% to 8%. Attached Figure Description

[0021] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on the provided drawings without creative effort.

[0022] Figure 1 Here is the structure diagram of the HSPA8 plasmid; Figure 2 For protein expression test results; MW: Marker; Ø: Uninduced strain (negative control); Expression test conditions: 1 mmol / L IPTG was used to induce expression at 16 ℃ / 16 h and 37 ℃ / 4 h, respectively; No.1: BL21(DE3) strain; No.2: T7E strain; Figure 3 To ensure the integrity of the sperm plasma membrane and acrosome in frozen yak semen without added protein; Figure 3 a. Plasma membrane integrity; Figure 3 b. Acrosome integrity; Figure 4 Results of sperm morphology and structure analysis in frozen semen after protein addition; Figure 4 a: Results of sperm motility testing in frozen semen after the addition of protein; Figure 4 b: Results of sperm plasma membrane integrity testing in frozen semen after protein addition; Figure 4 c: Results of sperm acrosome integrity testing in frozen semen after protein addition. Note: Different letters in the bar chart indicate significant differences (P<0.05); Figure 5 Results of sperm apoptosis rate analysis in frozen semen after protein addition; Figure 5 a~e: Results of apoptosis rate detection of sperm in frozen semen after thawing in groups with HSPA8 protein addition at concentrations of 0, 0.2, 0.5, 0.8, and 1.0 µg / mL, respectively; Figure 5 f: Statistical results of sperm apoptosis rate in different protein addition groups; Note: Different letters on the bar chart indicate significant differences (P<0.05). Detailed Implementation

[0023] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0024] Example 1 1. Reagents and Instruments 1-1. Main Reagents Peptone and yeast extract were purchased from Beijing Bairddi Biotechnology Co., Ltd.; isopropyl-β-D-thiogalactoside (IPTG) was purchased from Shanghai Aladdin Technology Co., Ltd.; sodium chloride (NaCl), glycerol, hydrochloric acid (HCl), potassium chloride (KCl), sodium dihydrogen phosphate dodecahydrate (Na2HPO4·12H2O), dipotassium hydrogen phosphate (K2HPO4), potassium dihydrogen phosphate (KH2PO4), and urea were all purchased from Sinopharm Chemical Reagent Co., Ltd.; sodium citrate and fructose were both purchased from Tianjin Zhiyuan Chemical Reagent Co., Ltd.; BL21(DE3) (EC0114) was purchased from Thermo. Scientific; T7E (C3016I) was purchased from New England Biotechnology (Beijing) Co., Ltd.; OptidyL sperm cryopreservation solution (2.5×) was purchased from IMV, France; Animal tissue / cell genomic DNA extraction kit, SDS-PAGE gel preparation kit, Coomassie brilliant blue staining solution, and Annexin V-FITC / PI apoptosis detection kit were purchased from Solarbio Technology Co., Ltd.

[0025] 1-2. Main Instruments and Equipment The electric thermostatic incubator (DNP-9082BS-Ⅲ) is a product of Shanghai Xinmiao Medical Instrument Co., Ltd.; the digital display thermostatic water bath (HH-11-2) is a product of Changzhou Nuoji Instrument Co., Ltd.; the full-temperature oscillating incubator (QHZ-98A) is a product of Guangzhou Shenhua Biotechnology Co., Ltd.; the benchtop high-speed centrifuge (TG16-WS) is a product of Hunan Pingfan Technology Co., Ltd.; the ultrasonic cell disruptor (JY92-IIN) and ultrasonic multi-channel disruptor (Scientz-6T) are products of Ningbo Xinzhi Biotechnology Co., Ltd.; the large-capacity refrigerated centrifuge (CR21N) is a product of Hitachi Limited; the artificial vagina and thermostatic microscope (JZ-B102) are products of Anhui Detu Tianmu Biotechnology Co., Ltd.; the animal sperm analyzer (GSA-610) is a product of Guangzhou Huayuexing Medical Technology Co., Ltd.; and the flow cytometer (Cytoflex) is a product of Beckman Coulter.

[0026] 2. Laboratory animals Three healthy bull yaks, with an average age of 5.5 years, were raised in Jiali County, Nagqu City, Tibet Autonomous Region. They were kept separately before semen collection and given supplemental nutrition including trace elements. The owners' informed consent was required for the start of the experiment and all procedures.

[0027] 3. Preparation of HSPA8 protein 3-1. Obtaining the complete HSPA8 genome sequence and synthesizing plasmids Yak ear tissue samples were collected, brought back to the laboratory at 4 ℃, and stored at -80 ℃. 20 mg of yak ear tissue samples were taken, and yak genomic DNA was extracted according to the instructions of the animal tissue / cell genomic DNA extraction kit. The whole-genome sequence of yak HSPA8 was then sequenced. The HSPA8 gene sequence was inserted during the synthesis of the empty vector plasmid to synthesize the corresponding expression plasmid. The plasmid uses a dual regulatory system of T7 promoter + lac operon, achieving high-efficiency expression only under IPTG induction. The N-terminus of the target gene HSPA8 is fused with a 6×His tag and a thrombin cleavage site. The multiple cloning site uses NdeI / XhoI double restriction enzyme sites to ensure directional insertion of HSPA8 and accurate reading frames. Simultaneously, f1 ori and KanR are retained to balance replication, selection, and downstream application flexibility (see [link to documentation]). Figure 1 ), and designed and synthesized the corresponding HSPA8 expression plasmid.

[0028] The nucleotide sequence of the yak HSPA8 protein (2019 bp) is shown in SEQ ID NO: 1: TAAGAATTC ; The amino acid sequence (670 residues) of the yak HSPA8 protein is shown in SEQ ID NO: 2: MGSSHHHHHHSSGLVPRGSHMSKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVP AYFNDSQRQATKDAGTIAGLNVLRIINEPTAATIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLD PVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDKSENVQDLLLLDVTPLSLGIETAGGVMTVLIKRNTTIPTKQTQTFTTYSDNQPGVLIQVYEGERAMTKDNNLLGKFELTGIPPAPRGVPQIEVTFDIDA NGILNVSAVDKSTGKENKITITNDKGRLSKEDIERMVQEAEKYKAEDEKQRDKVSSKNSLESYAFNMKATVEDEKLQGKINDEDKQKILDKCNEIINWLDKNQTAEKEEFEHQQKELEKVCNPIITKLYQSAGGMPGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD .

[0029] 3-2. Plasmid-transformed expression strains After designing and synthesizing the corresponding plasmid based on the HSPA8 full-gene sequence, the plasmid was transformed into competent cells. The specific procedure was as follows: 1–2 µL of plasmid was added to the prepared competent cells, placed on ice for 30 min, and then heat-shocked at 42 ℃ for 90 s. An appropriate amount of antibiotic-free LB liquid medium was added, and the cells were incubated at 37 ℃ and 150 r / min for 40 min. The incubated mixture was then spread onto LB solid culture dishes containing an antibiotic with matching resistance to the plasmid and incubated overnight at 37 ℃.

[0030] 3-3. Expression test of expression strain Single clones were picked from overnight culture dishes and transferred to 3 mL of LB medium containing an antibiotic with plasmid-matched resistance. The culture was incubated at 37 °C and 200 r / min for 3–4 h. 1.5 mL of the bacterial culture was transferred to a new 15 mL centrifuge tube, and 1.5 µL of IPTG (final concentration 1 mmol / L) was added. The culture was incubated at 37 °C and 200 r / min for 4 h. 1.5 µL of IPTG was added to the remaining 1.5 mL of the bacterial culture, and the culture was incubated overnight at 16 °C and 200 r / min. The induced bacterial culture was collected in a 1.5 mL centrifuge tube, centrifuged at 10000 g for 1 min, and the supernatant was discarded. 1 mL of 1×PBS (containing 8 mol / L urea) was added to the pellet, and the cells were lysed by sonication. 25 µL of 5× reducing loading buffer was then added to the sample, and the mixture was boiled for 10 min before SDS-PAGE analysis.

[0031] The results of the expression test show (see) Figure 2 When the induced strain was cultured at 37 ℃ for 4 h, it showed a clear band at the target position during SDS-PAGE analysis, and the expression level was significantly higher than that induced under the condition of overnight culture at 16 ℃.

[0032] 3-4. Amplify the expression Based on the test results in 3-3, the monoclonal expression strain was placed under the optimal expression conditions: 1 mmol / L IPTG, 37 ℃, 200 r / min, for large-scale induction culture.

[0033] 3-5. HSPA8 protein purification Collect the bacterial culture, centrifuge at 10000 g for 1 min, discard the supernatant, and lyse the cells with an appropriate amount of lysis buffer (PBS pH=7.5, 10% Glyerol, 1 mmol / L PMSF). After thorough mixing, lyse the cells using an ultrasonic homogenizer for 20 min. Centrifuge at 12000 g for 10 min, separate the supernatant (the mixture of supernatant and protein to be purified), and retain the precipitate. Add a certain amount of pre-treated Ni resin to the supernatant mixture, incubate in a shaker at 4 ℃ for 30 min, collect the resin, temporarily retain the breakthrough solution (FT), and then purify according to the steps in Table 1: Table 1 Purification Buffer

[0034] Samples (IN (starting sample), FT, W1, W2, W3, E1-E9) were taken for SDS-PAGE analysis, and the target protein was dialyzed into an appropriate buffer according to the results.

[0035] 3-6. Protein detoxification Add 1% Triton-114 to the purified protein and mix by rotation at 4 °C for 30 min; then incubate in a water bath at 37 °C for 10 min; after the water bath, centrifuge at 25 °C, 9000 g for 10 min; carefully aspirate the clear supernatant after centrifugation, which is the endotoxin-free target protein; aseptically filter, detect the protein concentration, and perform SDS-PAGE analysis. Store the final protein sample in PBS (pH=7.5), aliquot, and store at -80 °C.

[0036] The results showed that after endotoxin removal, the final HSPA8 protein sample SDS-PAGE showed a clear band near the 70 kDa standard protein marker band, with a concentration of 0.6 mg / mL. The protein purity was high, and the endotoxin content was <10 Eu / mL, which met the standard.

[0037] 4. Collection and quality testing of yak semen Semen was collected from male yaks after they were kept alone for 5-7 days. During collection, a fake vagina was assembled, 38°C hot water was injected, and the collection cup was fixed in place. A female yak in estrus was used to induce the male yak to mount. When the male yak mounted, his penis was quickly guided into the fake vagina. After ejaculation, the collection cup was quickly removed and stored at 37°C. The semen was then brought back to the laboratory for sperm density and sperm motility testing. Fresh semen that met the requirements of the "Technical Regulations for the Production of Frozen Yak Semen" (Standard No.: NY / T 3444-2019) was processed into frozen semen.

[0038] 5. HSPA8 protein addition test 5-1. Preparation of diluent Mix 0.25 mL of 0.6 mg / mL HSPA8 protein solution with 0.05 mL of pH 7.5 PBS to prepare a 0.5 mg / mL HSPA8 protein working solution. OptidyL sperm cryopreservation solution (2.5×) needs to be diluted with ddH2O at a ratio of 2:3 before use. As shown in Table 2, prepare the HSPA8 protein-added sperm cryopreservation dilution solution, mix well, and preheat at 37 ℃.

[0039] Table 2. Preparation of HSPA8 protein dilution buffer (10 mL)

[0040] 5-2. Preparation of frozen yak semen Based on sperm density counting results, the yak sperm density was adjusted to 2.0 × 10⁸ sperm / mL using different HSPA8 protein diluents. After dilution, the sperm was quickly filled into 0.25 mL cryogenic sperm tubes, wrapped in gauze, and equilibrated at 4℃ for 2–4 h. Then, the tubes were placed 3–5 cm above the liquid nitrogen surface for 8 min for fumigation, and then quickly placed in a cloth bag and stored in liquid nitrogen at -196 ℃.

[0041] 5-3. Frozen Semen Quality Testing Frozen semen was removed from liquid nitrogen at -196 °C and immediately thawed in a 37 °C water bath for 15–20 s. After thawing, frozen semen samples with different final HSPA8 protein concentrations were transferred to 2 mL centrifuge tubes and subjected to quality testing as follows: (1) Sperm motility test: OptidyL sperm cryopreservation solution was mixed with ddH2O at a ratio of 2:3 to form a diluent, and incubated in a 37 ℃ water bath. 5 µL of thawed semen was mixed with an appropriate amount of diluent to adjust the density, dropped onto a special slide for animal sperm analyzers, and placed under the microscope of the animal sperm analyzer for testing. Each test included at least 200 sperm cells, and was repeated 3 times.

[0042] (2) Sperm acrosome integrity test: 5 µL of semen was used to prepare a smear, stained with Coomassie brilliant blue for 30 min, rinsed off with a slow stream of water, and air-dried before analysis using an animal sperm analyzer. Each test was repeated at least 3 times, with at least 200 sperm analyzed each time (see...). Figure 3 ).

[0043] (3) Sperm plasma membrane integrity test: The hypotonic swelling test (HOST) was used. 10 µL of semen was added to 100 µL of hypotonic solution (prepared by dissolving 0.49 g sodium citrate and 0.9 g fructose in 100 mL of water). The mixture was incubated in a 37 ℃ water bath for 1 h. After incubation, 10 µL of the mixture was spread onto a glass slide and observed and counted under a microscope. Each test was repeated at least 3 times, with at least 200 sperm cells tested each time (see [link to test results]). Figure 3 ).

[0044] Sperm plasma membrane integrity = (Number of tail-curled sperm in the field of view / Total number of sperm in the field of view) × 100% (4) Sperm apoptosis rate detection: Sperm apoptosis rate was detected according to the Annexin V-FITC / PI apoptosis detection kit. Based on the sperm density count, at least 1×10⁶ sperm were collected, centrifuged at 300 rpm for 5 min, the supernatant was discarded, and the cells were washed with DPBS and resuspended in 500 µL of 1× Annexin V Binding Buffer. 5 μL of Annexin V-FITC Reagent and 5 μL of PI Reagent (50 μg / mL) were added, mixed well, and incubated in the dark for 15-20 min. The cells were then analyzed by flow cytometry. Each experiment was repeated 3 times.

[0045] The results showed that the addition of HSPA8 protein significantly improved sperm motility in frozen yak semen (P<0.05). The highest sperm motility was observed at a concentration of 0.8 µg / mL, significantly higher than the 0 µg / mL group (P<0.05), but there was no significant difference between the HSPA8 protein concentration and the 0.5 µg / mL group (P>0.05) (see [link to relevant documentation]). Figure 4 a) The addition of HSPA8 protein significantly improved the sperm plasma membrane integrity after thawing of frozen yak semen (P<0.05). The highest sperm plasma membrane integrity was observed at a concentration of 0.5 µg / mL, which was significantly higher than that of the 0, 0.2, 0.8, and 1.0 µg / mL groups (P<0.05) (see [link to HSPA8 protein list]). Figure 4 b); When the HSPA8 protein concentration reached 0.5 µg / mL, the acrosome integrity of yak frozen semen after thawing was significantly improved (P<0.05), and the acrosome integrity reached its highest value when the concentration reached 0.8 µg / mL (see [link to article]). Figure 4 c). Therefore, the addition of HSPA8 protein can, to some extent, improve the degree of sperm morphological and structural damage after thawing of yak frozen semen. Meanwhile, when the HSPA8 protein concentration was 0.5, 0.8, and 1.0 µg / mL, the sperm apoptosis rate of yak frozen semen was significantly lower than that of the 0 and 0.2 µg / mL groups (P<0.05); when the concentration reached 1.0 µg / mL, the sperm apoptosis rate reached its lowest point, indicating that HSPA8 protein can effectively reduce the sperm apoptosis rate after thawing of yak frozen semen and mitigate freezing damage (see c). Figure 5 Based on the comprehensive indicators of sperm motility, sperm plasma membrane integrity, and sperm acrosome integrity in frozen semen, the optimal addition concentration of HSPA8 in yak semen freezing was determined to be 0.8 µg / mL.

[0046] The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A protein additive for improving the quality of yak frozen semen, characterized in that, The protein additive is recombinant yak HSPA8 protein, with the amino acid sequence shown in SEQ ID NO:

2.

2. The protein additive according to claim 1, characterized in that, The recombinant yak HSPA8 protein was obtained by expression in the Escherichia coli expression system.

3. The protein additive according to claim 1, characterized in that, The concentration of the protein additive in the yak semen cryoprotectant is 0.5–1.0 µg / mL.

4. The protein additive according to claim 3, characterized in that, The concentration of the protein additive in the yak semen cryoprotectant is 0.8 µg / mL.

5. The use of the protein additive according to any one of claims 1-4 in the preparation of a cryoprotectant for yak semen.

6. A cryoprotectant for yak semen, characterized in that, It comprises the protein additive and sperm cryopreservation solution as described in any one of claims 1-4.

7. The yak semen cryoprotectant according to claim 6, characterized in that, The final concentration of the protein additive in the yak semen cryoprotectant is 0.8 µg / mL.

8. A method for preparing a protein additive to improve the quality of yak frozen semen, characterized in that, Includes the following steps: (1) Obtain the full gene sequence of HSPA8 from yak and synthesize HSPA8 expression plasmid; (2) The expression plasmid was transformed into competent E. coli cells, and positive clones were screened; (3) Positive clones were induced to express, the bacterial cells were collected and lysed, and the recombinant yak HSPA8 protein was obtained by purification.

9. The preparation method according to claim 8, characterized in that, The conditions for inducing expression in step (3) are: IPTG final concentration 1 mmol / L, 37 ℃, 200 r / min induction culture for 4 hours; the purification is performed by Ni resin affinity chromatography.

10. A method for improving the quality of frozen yak semen, characterized in that, Before cryopreservation of yak semen, the protein additive described in any one of claims 1-4 is added to the semen or sperm cryopreservation solution to make the final concentration of the protein additive 0.8 µg / mL.